USRuleOfficial ✓October 2, 2026· Federal Register
Global Benchmark for Efficient Drug Pricing (GLOBE) Model
What happened
This final rule, signed by Donald Trump, implements the Global Benchmark for Efficient Drug Pricing Model (GLOBE Model). It is a mandatory Medicare payment model that will test an alternative method for calculating Medicare Part B drug inflation rebate amounts. This applies to certain separately payable Medicare Part B drugs and biological products under Original Medicare.
Why it matters
The model aims to reduce costs for beneficiaries receiving Original Medicare and for the Medicare program itself. It seeks to achieve these savings while ensuring the quality of care is maintained.
Who it affects
- ›Original Medicare beneficiaries
- ›The Medicare program
- ›Manufacturers of certain Medicare Part B drugs
- ›Manufacturers of certain Medicare Part B biological products
Receipts
The receipts are official. The summary is ours.
Read on Federal Register ↗Summaries are generated from the official text and may simplify or omit nuance. The official document is the source of truth.
More from US
USNoticeOfficial ✓
Common Alloy Aluminum Sheet From the People's Republic of China: Initiation of Circumvention Inquiry of the Antidumping Duty and Countervailing Duty OrdersFederal Register·Oct 2, 2026
USRegulationOfficial ✓
Enhanced Transparency and Public Accountability of the Supervisory Stress Test Models and Scenarios; Modifications to the Capital Planning and Stress Capital Buffer Requirement Rule, Enhanced Prudential Standards Rule, and Regulation LLFederal Register·Oct 2, 2026
USRuleOfficial ✓
Federal Scholarship Tax CreditFederal Register·Oct 2, 2026